Pharmacogenetics of beta-blockers - Wikidata - awgldk - TriplyDB

Pharmacogenetics of beta-blockers

Pharmacogenetics of beta-blockers

http://www.wikidata.org/entity/Q24644448

about

Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders Physiology of in-situ arterial revascularization in coronary artery bypass grafting: Preoperative, intraoperative and postoperative factors and influences Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery.Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance Effects of β2-adrenergic receptor gene polymorphisms on ritodrine therapy in pregnant women with preterm labor: prospective follow-up study Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure Genetic variation, β-blockers, and perioperative myocardial infarction.Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.Pharmacogenomics of antihypertensive drugs: past, present and future Advancing management of hypertension through pharmacogenomics Progress toward personalized medicine for glaucoma Pharmacogenetics of ophthalmic topical beta-blockers.Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.Polypill: for Pollyanna.Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics Pharmacogenetics in heart failure: promises and challenges.Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Lost in translation: five grand challenges for proteomic biomarker discovery.Modulation of cardiac cytochrome P450 in patients with heart failure.Cardiovascular drugs and the genetic response.Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.Practical Pharmacogenomic Approaches to Heart Failure Therapeutics.Contextualizing Genetics for Regional Heart Failure Care Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Pharmacogenomics of heart failure: a systematic review.A metoprolol-terbinafine combination induced bradycardia.Pharmacogenomics and the failing heart are we waiting for godot?

P2860

Q26753129-BA67791B-93E7-4B07-BDE7-60BCA6B2CE82 Q28071493-907DC707-D757-4B53-A09F-6FF33AD503EE Q31063243-90D05DD9-9629-41B4-9C22-8D5F5359B344 Q33731708-6C42CB44-D6CE-4772-8ED7-571F52E7963D Q33776918-C91CB0A1-E0DC-4FB3-BCF2-5615318E0C1D Q34072541-D440B67E-E24C-4BC4-86C6-3A06CA9EE1EC Q34658477-8F47461A-B583-4F70-849B-C3E77F134C56 Q35033003-82FDA7D8-B08A-4D1B-A2C8-D6499AE8980A Q35046547-3E29CBD0-C8DC-4D00-A322-9597F1BDDA5F Q35117742-47C9642C-AAB1-43FB-9A36-D26941016D35 Q35580952-4BE6160D-FED2-43A0-AEFA-543367100012 Q36638124-5CBAEEBC-44A1-44B0-8336-621B836A7128 Q36828958-94A99879-B8A2-4D10-9E14-414574FE900C Q36902932-BC77FFDA-F5DC-4DD3-9009-554276799C53 Q36939501-994B7104-E5FF-4FA5-8088-70C0BAFCC365 Q37058798-4004A074-BE31-40B0-B52D-FFBBEE7A1721 Q37116485-C214F6B1-29C9-4233-AD02-D3B8383CAF11 Q37158873-6DDBA647-1B05-4082-B741-09B87C22EB89 Q37175268-FAA41AA2-9241-44D0-A620-937465A07DE2 Q37233317-098424C7-3FFA-4E24-BD23-F45080D916B7 Q37244546-0E568253-7F81-41FC-A539-B5174F078F8B Q37276490-D38BCB8C-5AA1-4CA5-9E34-CA3B5B58C24F Q37532571-0541FCB0-480A-475A-AB66-41FD88B89738 Q37742683-D4F7662B-84FF-45BB-8917-BCF7229B700C Q38012491-521D7E0F-3EE9-4E94-A310-8FFE3C05FC79 Q38089257-16A3E3B7-1956-43F6-B09C-55AE3C8DC737 Q38175461-2751D4FD-56D5-484A-BF58-800F9EA0DC9A Q38220502-EFDD4481-14E7-4F13-8397-D76F5C1E9EEE Q38371163-9FBF0565-9FA8-465A-B1CF-7442F2FF539B Q38827323-E311F408-381A-4280-B521-C2D12E59CD36 Q38859880-4958C60F-87DC-4A58-ACA0-795CD7D453A0 Q38974781-DFA45CE1-78F2-4AD7-9066-A9943C6BB68E Q38998634-74C8747B-E482-4929-98FA-F2C0BA97437B Q42705397-C5E3520C-12AE-4ED6-B85F-35CF62F66FF3 Q43159114-21C89965-C160-4638-B229-72866043471A

P2860

Pharmacogenetics of beta-blockers

http://www.wikidata.org/entity/Q24644448

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Pharmacogenetics of beta-blockers

@ast

Pharmacogenetics of beta-blockers

@en

Pharmacogenetics of beta-blockers

@nl

type

label

Pharmacogenetics of beta-blockers

@ast

Pharmacogenetics of beta-blockers

@en

Pharmacogenetics of beta-blockers

@nl

prefLabel

Pharmacogenetics of beta-blockers

@ast

Pharmacogenetics of beta-blockers

@en

Pharmacogenetics of beta-blockers

@nl

P1433

Q24644448-1CE50D6E-2E52-4209-A8E9-0F672601B7E8

P1476

Q24644448-DEF102DB-69F1-4AF6-BD1F-AE486245613A

P2093

Q24644448-4F0D76C9-0504-4E39-83FF-A68CB94A05FF

Q24644448-53B7F9B3-CF33-46DB-9D74-6C7A7DB73F25

P2860

Q24644448-008997DF-07C6-4AD3-B6FF-78C6C6E78D13

Q24644448-00FF3516-2EC2-4A14-990B-FBEDC45CE8D2

Q24644448-016813F7-C425-4082-AF64-3300651CD710

Q24644448-02C285E4-E731-43C7-8957-333E9E33B15C

Q24644448-031CB1B1-C8CB-4B91-95C8-E23A65A61D8F

Q24644448-0C52B4E2-2082-4BCD-9EB8-F9DAAEBABBF8

Q24644448-1310F9D2-0949-4691-9D0A-C29004C7FCDD

Q24644448-1454B2AC-D26B-4F14-B657-6C4B2F3E1E12

Q24644448-172DCFE9-6CBB-4FC6-81AF-C8B51C4FBCEB

Q24644448-1C3A8D82-2130-42C9-B6AB-66EF3EFB8FEC

P304

Q24644448-6CBC61A7-BF48-4412-8817-D96323734E76

P31

Q24644448-5AB00BA0-C52C-48D8-A3A1-2FDA5E682093

P3181

Q24644448-498D03F1-B690-4EC9-9C3D-F485E6B4A277

P356

Q24644448-F7C171E2-AE69-49AC-A3EB-5BCE5EEEB696

P407

Q24644448-66D3C96C-26B3-48B0-97C0-79AF4330C440

P433

Q24644448-E19CBBC5-9566-40CA-AEB0-12A7467B67AA

P478

Q24644448-EB853C6A-A7BC-4467-84E1-1703E44F49D0

P577

Q24644448-809D7261-B260-46A6-BD24-366CAC6987DF

P5875

Q24644448-EB6808FA-C4EE-47E4-9D38-55F29CDCD0F3

P698

Q24644448-2AF593DB-E2E6-4984-9DFA-7D400D77E3CE

P932

Q24644448-F8177F53-35AA-4BA6-8D1E-C6D8C96560E3

P3181

P356

P1433

Pharmacotherapy

P1476

Pharmacogenetics of beta-blockers

@en

P2093

Jaekyu Shin

http://www.w3.org/2001/XMLSchema#string

Julie A Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy

Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.

Drug-drug interactions of beta-adrenoceptor blockers.

P304

874-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2127065

http://www.w3.org/2001/XMLSchema#string

P356

10.1592/PHCO.27.6.874

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6293177

http://www.w3.org/2001/XMLSchema#string

P698

17542770

http://www.w3.org/2001/XMLSchema#string

P932

2735790

http://www.w3.org/2001/XMLSchema#string